Michael Gelband’s Arvinas ARVN Stock Holding History

Michael Gelband’s Portfolio ARVN Stock Details ARVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$423K	Sell	50,933 -200,079	-80%	-$1.87M	﹤0.01%	1280
2026 Q1	$2.66M	Buy	251,012 +62,104	+33%	+$769K	0.02%	661
2025 Q4	$2.24M	Sell	188,908 -52,590	-22%	-$574K	0.02%	729
2025 Q3	$2.06M	Buy	+241,498	New	+$1.83M	0.02%	724
2025 Q2	–	Sell	-63,052	Closed	-$443K	–	1451
2025 Q1	$443K	Buy	+63,052	New	+$988K	﹤0.01%	1136
2023 Q3	–	Sell	-27,755	Closed	-$689K	–	1682
2023 Q2	$689K	Buy	27,755 +13,938	+101%	+$358K	0.01%	1239
2023 Q1	$377K	Buy	+13,817	New	+$436K	﹤0.01%	1412
2022 Q3	–	Sell	-30,697	Closed	-$1.29M	–	1859
2022 Q2	$1.29M	Buy	+30,697	New	+$1.54M	0.02%	962
2020 Q4	–	Sell	-20,560	Closed	-$485K	–	1942
2020 Q3	$485K	Buy	+20,560	New	+$596K	0.01%	1037
2019 Q3	–	Sell	-13,000	Closed	-$286K	–	1321
2019 Q2	$286K	Buy	+13,000	New	+$273K	0.01%	720

Other funds holding ARVN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Michael Gelband's ARVN Position: Q2 2026 in Review

Michael Gelband reduced its Arvinas (ARVN) stake by 80% in Q2 2026, selling an estimated $1.87M and leaving 50,933 shares worth $423K. The position accounts for ﹤0.01% of the portfolio, ranked #1280.

Michael Gelband first reported a position in ARVN in Q2 2019 and has held it in 10 quarters since. The position peaked at $2.66M in Q1 2026. 198 funds tracked by Wall St. Rank hold ARVN as of Q2 2026.

Michael Gelband held 50,933 shares of Arvinas worth $423K as of Q2 2026.
Michael Gelband sold 200,079 Arvinas shares in Q2 2026, an estimated $1.87M.
Arvinas made up ﹤0.01% of Michael Gelband's portfolio in Q2 2026, its #1280 holding.
Michael Gelband first reported a position in Arvinas in Q2 2019 and has held it in 10 quarters since.
Michael Gelband's Arvinas position peaked at $2.66M in Q1 2026.
198 funds tracked by Wall St. Rank held Arvinas as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.